Top Pharma stocks: Halozyme Therapeutics, Keryx Biopharmaceuticals, Sunesis Pharmaceuticals, Merck & Co, Arena Pharmaceuticals

NEW YORK, September 21, 2012 - Marketsareopen, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Halozyme Therapeutics, Keryx Biopharmaceuticals, Sunesis Pharmaceuticals, Merck & Co, Arena Pharmaceuticals.Halozyme Therapeutics, Inc.(NASDAQ:HALO) shares surged 27.93% to $8.21 after ViroPharma and HALO announced the U.S. Food & Drug Administration has provided guidance enabling ViroPharma to resume clinical studies of the subcutaneous administration of Cinryze in combination with rHuPH20. The FDA has advised ViroPharma to amend the study protocol, allowing for increased laboratory sampling to monitor rHuPH20 antibody levels, and keep the Agency informed of elevated antibody levels during the treatment phase of the study. Will HALO Continue To Move Higher? Find Out Here Biopharmaceuticals(NASDAQ:KERX) shares jumped 14.92% to $2.85. Keryx‘s stock had its “outperform” rating reaffirmed by research analysts at Oppenheimer in a report released on Sept. 5. Additionally, analysts predict that Keryx Biopharmaceuticals will post $-0.30 earnings per share for the current fiscal year. KERX is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.Should Investors Buy KERX At Current Market Price? Find Out Here Pharmaceuticals, Inc.(NASDAQ:SNSS) shares climbed 11.90% to $5.65 after Cowen reconfirmed their outperform rating on shares of SNSS. Additionally, the company announced the closing of two previously disclosed financings. Royalty Pharma has invested $25.0 million under its royalty arrangement with Sunesis, and, in a separate transaction, a syndicate of lenders have funded the second tranche of $15.0 million under their $25.0 million loan facility with the company.Will SNSS Hit $10 This Year? Find Out Here & Co., Inc.(NYSE:MRK) shares gained 0.38% to $45.06 in the morning hour. The shares of Merck‘s stock had its “neutral” rating reiterated by equities research analysts at Cowen in a research note issued to investors today. MRK has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Merck & Co in a research note to investors on September 6. They now have a $46.00 price target on the stock.Will MRKContinue To Move Higher? Find Out Here Pharmaceuticals, Inc.(NASDAQ:ARNA) shares jumped 3.76% to $9.11. Investment analysts at Credit Suisse initiated coverage on shares of Arena Pharmaceuticals in a note issued to investors on Sept. 6. The firm set an “underperform” rating and a $6.00 price target on the stock. The 52 week trading range for the company is $1.23 - $13.50. The shares of the company climbed 500% in the last one year.Will ARNA Continue To Move Higher? Find Out Here MarketsareopenMarketsareopen’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Marketsareopen’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.Contacts:Marketsareopen1419 Westwood Blvd Los Angeles,

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here